Potassium-sparing diuretic (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Potassium-sparing diuretic" in English language version.

refsWebsite

Global rank English rank

16doi.org

2^nd place

16nih.gov

4^th place

4worldcat.org

5^th place

2wiley.com

222^nd place

297^th place

2sagepub.com

731^st place

638^th place

doi.org

Knepper, Mark A.; Kleyman, Thomas; Gamba, Gerardo (2005), "Diuretics: Mechanisms of Action", Hypertension, Elsevier, pp. 638–652, doi:10.1016/b978-0-7216-0258-5.50152-6, ISBN 978-0-7216-0258-5, retrieved 2024-03-24
Rose BD (February 1991). "Diuretics". Kidney Int. 39 (2): 336–52. doi:10.1038/ki.1991.43. PMID 2002648.
Weber KT, Villarreal D (January 1993). "Aldosterone and antialdosterone therapy in congestive heart failure". The American Journal of Cardiology. 71 (3): A3 – A11. doi:10.1016/0002-9149(93)90238-8. PMID 8422002.
Martin KA, Anderson RB, et al. (1 April 2018). "Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society* Clinical Practice Guideline". The Journal of Clinical Endocrinology & Metabolism. 103 (4): 1233–1257. doi:10.1210/jc.2018-00241. PMID 29522147.
Grandhi R, Alikhan A (2017). "Spironolactone for the Treatment of Acne: A 4-Year Retrospective Study". Dermatology. 233 (2–3): 141–144. doi:10.1159/000471799. PMID 28472793.
Sica DA, Gehr TW (1989). "Triamterene and the Kidney". Nephron. 51 (4): 454–461. doi:10.1159/000185375. PMID 2662034.
Lainscak M, Pelliccia F, et al. (December 2015). "Safety profile of mineralocorticoid receptor antagonists: Spironolactone and eplerenone". International Journal of Cardiology. 200: 25–29. doi:10.1016/j.ijcard.2015.05.127. PMID 26404748.
Struthers, Allan; Krum, Henry; Williams, Gordon H. (April 2008). "A Comparison of the Aldosterone-blocking Agents Eplerenone and Spironolactone". Clinical Cardiology. 31 (4): 153–158. doi:10.1002/clc.20324. ISSN 0160-9289. PMC 6652937. PMID 18404673.
Batterink, Josh; Stabler, Sarah N; Tejani, Aaron M; Fowkes, Curt T (2010-08-04). Cochrane Hypertension Group (ed.). "Spironolactone for hypertension". Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD008169.pub2.
Horisberger J, Giebisch G (1987). "Potassium-Sparing Diuretics". Kidney and Blood Pressure Research. 10 (3–4): 198–220. doi:10.1159/000173130. PMID 2455308.
Hropot M, Fowler N, Karlmark B, Giebisch G (September 1985). "Tubular action of diuretics: Distal effects on electrolyte transport and acidification". Kidney International. 28 (3): 477–489. doi:10.1038/ki.1985.154. PMID 4068482.
Modell JH, Graves SA, Ketover A (August 1976). "Clinical course of 91 consecutive near-drowning victims". Chest. 70 (2): 231–8. doi:10.1378/chest.70.2.231. PMID 780069.
Batterink, Josh; Stabler, Sarah N; Tejani, Aaron M; Fowkes, Curt T (2010-08-04). Cochrane Hypertension Group (ed.). "Spironolactone for hypertension". Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD008169.pub2.
Struthers, Allan; Krum, Henry; Williams, Gordon H. (April 2008). "A Comparison of the Aldosterone-blocking Agents Eplerenone and Spironolactone". Clinical Cardiology. 31 (4): 153–158. doi:10.1002/clc.20324. ISSN 0160-9289. PMC 6652937. PMID 18404673.
Marrs, Joel C (November 2010). "Spironolactone Management of Resistant Hypertension". Annals of Pharmacotherapy. 44 (11): 1762–1769. doi:10.1345/aph.1P338. ISSN 1060-0280. PMID 20978214 – via National Library of Medicine.
Marrs, Joel C (November 2010). "Spironolactone Management of Resistant Hypertension". Annals of Pharmacotherapy. 44 (11): 1762–1769. doi:10.1345/aph.1P338. ISSN 1060-0280. PMID 20978214 – via National Library of Medicine.

nih.gov

pubmed.ncbi.nlm.nih.gov

Rose BD (February 1991). "Diuretics". Kidney Int. 39 (2): 336–52. doi:10.1038/ki.1991.43. PMID 2002648.
Weber KT, Villarreal D (January 1993). "Aldosterone and antialdosterone therapy in congestive heart failure". The American Journal of Cardiology. 71 (3): A3 – A11. doi:10.1016/0002-9149(93)90238-8. PMID 8422002.
Martin KA, Anderson RB, et al. (1 April 2018). "Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society* Clinical Practice Guideline". The Journal of Clinical Endocrinology & Metabolism. 103 (4): 1233–1257. doi:10.1210/jc.2018-00241. PMID 29522147.
Grandhi R, Alikhan A (2017). "Spironolactone for the Treatment of Acne: A 4-Year Retrospective Study". Dermatology. 233 (2–3): 141–144. doi:10.1159/000471799. PMID 28472793.
Sica DA, Gehr TW (1989). "Triamterene and the Kidney". Nephron. 51 (4): 454–461. doi:10.1159/000185375. PMID 2662034.
Lainscak M, Pelliccia F, et al. (December 2015). "Safety profile of mineralocorticoid receptor antagonists: Spironolactone and eplerenone". International Journal of Cardiology. 200: 25–29. doi:10.1016/j.ijcard.2015.05.127. PMID 26404748.
Struthers, Allan; Krum, Henry; Williams, Gordon H. (April 2008). "A Comparison of the Aldosterone-blocking Agents Eplerenone and Spironolactone". Clinical Cardiology. 31 (4): 153–158. doi:10.1002/clc.20324. ISSN 0160-9289. PMC 6652937. PMID 18404673.
Horisberger J, Giebisch G (1987). "Potassium-Sparing Diuretics". Kidney and Blood Pressure Research. 10 (3–4): 198–220. doi:10.1159/000173130. PMID 2455308.
Hropot M, Fowler N, Karlmark B, Giebisch G (September 1985). "Tubular action of diuretics: Distal effects on electrolyte transport and acidification". Kidney International. 28 (3): 477–489. doi:10.1038/ki.1985.154. PMID 4068482.
Modell JH, Graves SA, Ketover A (August 1976). "Clinical course of 91 consecutive near-drowning victims". Chest. 70 (2): 231–8. doi:10.1378/chest.70.2.231. PMID 780069.
Fairley KF, Woo KT, Birch DF, Leaker BR, Ratnaike S (October 1986). "Triamterene-induced crystalluria and cylinduria: clinical and experimental studies". Clinical Nephrology. 26 (4): 169–73. PMID 3780069.
Struthers, Allan; Krum, Henry; Williams, Gordon H. (April 2008). "A Comparison of the Aldosterone-blocking Agents Eplerenone and Spironolactone". Clinical Cardiology. 31 (4): 153–158. doi:10.1002/clc.20324. ISSN 0160-9289. PMC 6652937. PMID 18404673.
Marrs, Joel C (November 2010). "Spironolactone Management of Resistant Hypertension". Annals of Pharmacotherapy. 44 (11): 1762–1769. doi:10.1345/aph.1P338. ISSN 1060-0280. PMID 20978214 – via National Library of Medicine.
Marrs, Joel C (November 2010). "Spironolactone Management of Resistant Hypertension". Annals of Pharmacotherapy. 44 (11): 1762–1769. doi:10.1345/aph.1P338. ISSN 1060-0280. PMID 20978214 – via National Library of Medicine.

ncbi.nlm.nih.gov

Struthers, Allan; Krum, Henry; Williams, Gordon H. (April 2008). "A Comparison of the Aldosterone-blocking Agents Eplerenone and Spironolactone". Clinical Cardiology. 31 (4): 153–158. doi:10.1002/clc.20324. ISSN 0160-9289. PMC 6652937. PMID 18404673.
Struthers, Allan; Krum, Henry; Williams, Gordon H. (April 2008). "A Comparison of the Aldosterone-blocking Agents Eplerenone and Spironolactone". Clinical Cardiology. 31 (4): 153–158. doi:10.1002/clc.20324. ISSN 0160-9289. PMC 6652937. PMID 18404673.

sagepub.com

journals.sagepub.com

Marrs, Joel C (November 2010). "Spironolactone Management of Resistant Hypertension". Annals of Pharmacotherapy. 44 (11): 1762–1769. doi:10.1345/aph.1P338. ISSN 1060-0280. PMID 20978214 – via National Library of Medicine.
Marrs, Joel C (November 2010). "Spironolactone Management of Resistant Hypertension". Annals of Pharmacotherapy. 44 (11): 1762–1769. doi:10.1345/aph.1P338. ISSN 1060-0280. PMID 20978214 – via National Library of Medicine.

wiley.com

doi.wiley.com

Batterink, Josh; Stabler, Sarah N; Tejani, Aaron M; Fowkes, Curt T (2010-08-04). Cochrane Hypertension Group (ed.). "Spironolactone for hypertension". Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD008169.pub2.
Batterink, Josh; Stabler, Sarah N; Tejani, Aaron M; Fowkes, Curt T (2010-08-04). Cochrane Hypertension Group (ed.). "Spironolactone for hypertension". Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD008169.pub2.

worldcat.org

search.worldcat.org

Struthers, Allan; Krum, Henry; Williams, Gordon H. (April 2008). "A Comparison of the Aldosterone-blocking Agents Eplerenone and Spironolactone". Clinical Cardiology. 31 (4): 153–158. doi:10.1002/clc.20324. ISSN 0160-9289. PMC 6652937. PMID 18404673.
Struthers, Allan; Krum, Henry; Williams, Gordon H. (April 2008). "A Comparison of the Aldosterone-blocking Agents Eplerenone and Spironolactone". Clinical Cardiology. 31 (4): 153–158. doi:10.1002/clc.20324. ISSN 0160-9289. PMC 6652937. PMID 18404673.
Marrs, Joel C (November 2010). "Spironolactone Management of Resistant Hypertension". Annals of Pharmacotherapy. 44 (11): 1762–1769. doi:10.1345/aph.1P338. ISSN 1060-0280. PMID 20978214 – via National Library of Medicine.
Marrs, Joel C (November 2010). "Spironolactone Management of Resistant Hypertension". Annals of Pharmacotherapy. 44 (11): 1762–1769. doi:10.1345/aph.1P338. ISSN 1060-0280. PMID 20978214 – via National Library of Medicine.